Home » Pre-clinical Imaging » Mediso nanoScan PET/MRI

Mediso nanoScan PET/MRI

Name: Mediso nanoScan PET/MRI
Brand: Mediso

Overview

Mediso is world leading manufacturer of clinical and pre-clinical multi modal in-vivo imaging systems that combine nuclear imaging together with MRI (3T,7T) and CT. The Nanoscan product line is leading the world of pre-clinical research with best in class resolution and sensitivity.

Use Cases

Molecular imaging and tracer development: quantitative PET or SPECT for characterising new tracers.
Oncology, neurology and cardiology research: functional signal localised against anatomy.
Drug development and biodistribution: following where a compound goes and how long it stays.
Longitudinal quantitative studies: the same animal measured repeatedly over a study.
Hybrid configurations to suit the science: PET/CT, PET/MRI at 3T or 7T, SPECT/CT, a triple SPECT/CT/PET, standalone MRI, and the MultiScan LFER150.

Unique Benefits

Hybrid by design: a molecular modality fused with an anatomical one, so functional signal lands exactly where it belongs in the body.
Clinical-grade tomography on the bench: resolution and sensitivity at the top of the preclinical class.
Quantitative: the output is a number that can be compared across timepoints and animals, not only a picture.
Cryogen-free MRI option: removing the infrastructure burden of a cryogen-cooled magnet.
Configurable: the modality combination is chosen for the research question rather than fixed.
Local support from Merkel: demonstration on your own samples, installation, training and service in Israel.

Resources

Mediso nanoScan PET/MRI

Mediso nanoScan PET/MRI

To get more information or a quote for this product